Piclamilast
Piclamilast (RP 73401) is a selective phosphodiesterase 4 (PDE4) inhibitor used in research to study inflammatory pathways. It has been applied in both in vitro and in vivo models to investigate conditions such as asthma, COPD, and other inflammatory diseases.
Product Specifications
CAS Number
144035-83-6
Product Name Alternative
AML, ATRA, cAMP, inhibit, PDE4, PDE, Inhibitor, RP 73401, RP73401, RP-73401, RPR73401, RPR-73401, RPR 73401, phosphodiesterase, Phosphodiesterase (PDE), RAR, Piclamilast
Field of Research
Metabolism Research
Purity
98.28% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:2 mg/mL (5.25 mM) ; DMSO:30 mg/mL (78.69 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble)
Smiles
COc1ccc (cc1OC1CCCC1) C (=O) Nc1c (Cl) cncc1Cl
Molecular Formula
C18H18Cl2N2O3
Molecular Weight
381.25
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6505601-01 0.1 mL
VEGFR-2, Phosphorylated (Tyr951) (Vascular Endothelial Growth Factor Receptor 2, VEGFR-2, Kinase Insert Domain Receptor, Protein-tyrosine Kinase Receptor Flk-1, Fetal Liver Kinase 1, FLK-1, CD309 antigen, KDR, FLK1) (MaxLight 405)
Sign In for Pricing
View Details MBS6505601-02 5x 0.1 mL
VEGFR-2, Phosphorylated (Tyr951) (Vascular Endothelial Growth Factor Receptor 2, VEGFR-2, Kinase Insert Domain Receptor, Protein-tyrosine Kinase Receptor Flk-1, Fetal Liver Kinase 1, FLK-1, CD309 antigen, KDR, FLK1) (MaxLight 405)
Sign In for Pricing
View Details